Clinical trial

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

NCT07008664

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-03-31

PhaseN/A

Study timeline

Study start (actual)2025-03-31Date precision: day

Registry last updated2026-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Lung Cancer Screeningunresolved

Healthy Volunteers (HV)unresolved

Unhealthy Volunteersunresolved

Interventions

Epigenetic Signature AssayOTHER

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

EPOCH Epigenetics, Inccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07008664 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.